| News

Fully equipped lab spaces at the Switzerland Innovation Park Basel Area

29.04.2019

Launching a biotech is a daunting endeavor. Resources – both human and capital - are scarce and have to be fully dedicated to advancing science and building the company. Unfortunately, a significant amount of the initial capital, time and energy are often spent on setting up lab infrastructure: This includes negotiations with suppliers, wait times of months until equipment arrives, getting all the necessary permits, taking on the financial risk of signing long-term lease agreements, and much more.

For that reason, BaselArea.swiss has set up fully-equipped, permitted shared lab and office space at the Switzerland Innovation Park Basel Area, which takes care of all of the above.

The lab rental package

The package includes ready-to-go labs where companies can rent one or more benches with access to shakers and incubators, fridges and freezers, autoclaves, ice machines, PCR and qPCR machines, various plate readers and imaging stations, HPLCs, rotavaps, chemical hoods, microscopes, cell culture facilities (up to BSL-2 safety levels), and much more. Also included are office desks, meeting rooms, printers, and internet access. The package comes with flexible and short-term rental contracts. And the best part is that there is a dedicated lab manager on site to take care of everything from equipment maintenance and the relevant permits to safety procedures, waste management, introductions to the various equipment, and more.

Start working right away

The lab has been in operation since 2018; the first tenants took up work in May 2018. One of them is Skyhawk Therapeutics, a Boston-based company that initially opened up a small outpost in the Basel region.

Kathleen McCarthy, CSO Skyhawk Therapeutics: “Starting research operations in Europe was an easy decision as the fully-equipped lab infrastructure in the Switzerland Innovation Park Basel Area allowed us to do so very leanly at the beginning. And it provided us with a head start so we could focus entirely on the science from day one.” Things went so well that the company has been expanding rapidly in recent months. It has already outgrown the shared lab environment and is moving into its own labs in the Technologiepark Basel.

At the same time, Versameb and Polyneuron started with small teams in the shared labs. Both companies are supported by BaseLaunch which provided them with complimentary infrastructure access for one year.

Friedrich Metzger, CEO Versameb: “Setting up our research operations in the shared lab was crucial because we could start working on advancing science right away, producing more data, and expanding our technology platform. We didn’t have to spend time or money on establishing our own lab infrastructure.” Versameb and Polyneuron are growing rapidly and have just moved into their own labs which are also located in the Technologiepark Basel.

All a company needs to do is move in. With good timing, employees can start work on the very first day and focus completely on what is most important at the beginning, namely, generating data to further advance science and build the company.

If you are interested in learning more about the lab space or start-up operations, please contact us. Or directly apply to BaseLaunch. Should you be selected, we can provide complimentary access to the lab.

Share this article

Sign up to receive our newsletter in your inbox.

You might also be interested in

VectivBio secures investments totaling 110 million dollars
Basel Area Business & Innovation, Innovation, Invest

VectivBio secures investments totaling 110 million dollars

The Basel-based biotechnology firm VectivBio has received a capital injection of 110 million US dollars from both new and existing...

Read More
Polyphor receives up to 18 million dollars for development of antibiotics
Basel Area Business & Innovation, Innovation, Invest

Polyphor receives up to 18 million dollars for development of antibiotics

The Allschwil-based company Polyphor has received a second funding award from the global consortium CARB-X to combat antimicrobial resistance. Polyphor...

Read More
What makes Switzerland’s economy resilient in face of COVID pandemic
Basel Area Business & Innovation, Invest

What makes Switzerland’s economy resilient in face of COVID pandemic

The COVID-19 pandemic has hit economies worldwide – and we have not yet overcome it. However, Switzerland is among the...

Read More
DayOne Accelerator applications open
Basel Area Business & Innovation, Innovation

DayOne Accelerator applications open

We are excited to announce the opening of the call for the DayOne Accelerator, now in its 3rd year!

Read More
Matériaux Sabag printing concrete elements
Basel Area Business & Innovation, Innovation, Invest

Matériaux Sabag printing concrete elements

The Jura-based company Matériaux Sabag is now using a 3D printing solution to produce its concrete elements. This approach allows...

Read More
Six companies win the i4Challenge
Basel Area Business & Innovation, Innovation

Six companies win the i4Challenge

The i4Challenge expert jury has selected six winners from 18 finalists. The Industry 4.0 solutions range from 3D printing, IoT,...

Read More
Monte Rosa Therapeutics banks 96 million US dollars
Basel Area Business & Innovation, Innovation, Invest

Monte Rosa Therapeutics banks 96 million US dollars

The Basel-based biotechnology firm Monte Rosa Therapeutics has raised a total of 96 million US dollars after closing a successful...

Read More
Roche launches new coronavirus antibody test
Basel Area Business & Innovation, Innovation, Invest

Roche launches new coronavirus antibody test

Roche is launching on the market a new antibody test to determine coronavirus infections. This should help with the development...

Read More
Investors see great potential in Polyneuron
Basel Area Business & Innovation, Innovation, Invest

Investors see great potential in Polyneuron

The Basel-based company Polyneuron Pharmaceuticals extended its Series A funding round and has now raised a total of 36.5 million...

Read More
Lonza set to manufacture coronavirus drug for Humanigen
Basel Area Business & Innovation, Innovation, Invest

Lonza set to manufacture coronavirus drug for Humanigen

The Basel-based pharmaceutical supplier Lonza is supporting the US firm Humanigen in the development of a potential coronavirus therapeutic. Lonza...

Read More
1 2 3 21

Do you have a question? We'd like to hear from you.